Tag: Carfilzomib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Carfilzomib

DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance

Added to Collection on: 2025-03-20 21:39:56

Tags for this article:

Orphan drugs
Daratumumab/hyaluronidase
Daratumumab
Isatuximab
Multiple myeloma
Carfilzomib
Lenalidomide
Elotuzumab
Pomalidomide
Proteasome inhibitor
Hyaluronidase
Bortezomib
Melphalan
Prednisone

Click the tags to see associated articles and topics

View Article Details
Elotuzumab Plus PVd May Be Effective in Relapsed, Refractory MM - Hematology Advisor

Added to Collection on: 2025-04-25 13:32:36

Tags for this article:

Orphan drugs
Elotuzumab
Multiple myeloma
SLAMF7
Bortezomib
Pomalidomide
Proteasome inhibitor
Carfilzomib
Filanesib

Click the tags to see associated articles and topics

View Article Details
Newer Trials Explore High-Risk Treatment and MRD in Multiple Myeloma

Added to Collection on: 2025-05-08 21:11:44

Tags for this article:

Orphan drugs
Multiple myeloma
Isatuximab
UPMC Hillman Cancer Center
Lenalidomide
Carfilzomib
Dexamethasone

Click the tags to see associated articles and topics

View Article Details
FDA Grants Fast Track Designation to IBS 2001, An Investigational Trispecific Antibody for ...

Added to Collection on: 2025-05-08 17:28:54

Tags for this article:

Orphan drugs
Multiple myeloma
Bispecific monoclonal antibody
Isatuximab
Carfilzomib

Click the tags to see associated articles and topics

View Article Details
Treatment Line Trends In The European Multiple Myeloma Therapeutics Market

Added to Collection on: 2025-05-13 10:37:09

Tags for this article:

Orphan drugs
Isatuximab
Multiple myeloma
Selinexor
Daratumumab
Carfilzomib
Lenalidomide
Elotuzumab
Pomalidomide
Proteasome inhibitor
Bortezomib
Dexamethasone

Click the tags to see associated articles and topics

View Article Details
Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial ...

Added to Collection on: 2025-05-23 20:43:53

Tags for this article:

Orphan drugs
Multiple myeloma
Carfilzomib
Regeneron Pharmaceuticals
Casirivimab/imdevimab
Checkpoint inhibitor
Isatuximab
Filanesib
Bortezomib
United States

Click the tags to see associated articles and topics

View Article Details
MRD Monitoring May Help Redefine Long-Term Goals in Myeloma Therapy

Added to Collection on: 2025-06-01 23:28:31

Tags for this article:

Immunosuppressants
Oncology
Leukemia
Minimal residual disease
Orphan drugs
Multiple myeloma
Lenalidomide
Carfilzomib
MRD
Celgene
Cereblon E3 ligase modulator
Cancer treatment

Click the tags to see associated articles and topics

View Article Details
Elotuzumab Plus PVd May Be Effective in Relapsed, Refractory MM

Added to Collection on: 2025-07-11 13:09:29

Tags for this article:

Orphan drugs
Elotuzumab
Multiple myeloma
SLAMF7
Bortezomib
Pomalidomide
Proteasome inhibitor
Carfilzomib
Filanesib

Click the tags to see associated articles and topics

View Article Details
Multiple Myeloma Market Size to Reach USD 46.94 Billion by 2032 - GlobeNewswire

Added to Collection on: 2025-08-08 16:31:08

Tags for this article:

Orphan drugs
Immunosuppressants
Antineoplastic drugs
Aromatic amines
Phthalimides
Multiple myeloma
Isatuximab
Daratumumab
Lenalidomide
Cereblon E3 ligase modulator
Carfilzomib
Targeted therapy

Click the tags to see associated articles and topics

View Article Details
Bristol touts its first pivotal celmod win | ApexOnco - Oncology Pipeline

Added to Collection on: 2025-09-24 19:52:28

Tags for this article:

Orphan drugs
Immunosuppressants
Aromatic amines
Phthalimides
Antineoplastic drugs
Lenalidomide
Dexamethasone
Daratumumab
Pomalidomide
Bortezomib
Carfilzomib
Multiple myeloma
Velcade
Bristol
Bristol-Myers Squibb
Revlimid

Click the tags to see associated articles and topics

View Article Details
Book a Demo